NYSE
52.22USD
+2.01 (+4.00%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.5B
P/E
—
EPS
—
Beta
0.67
52W range
38.91-147.03
Day range
51.21–52.80
Open
51.23
Prev close
50.21
Volume
962.7K
Avg volume
1.2M
Dividend
9.00
IPO
2018-05-03
https://www.zacks.com/stock/news/2967034/inspire-medical-systems-insp-q2-earnings-and-revenues-beat-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_4-2967034 · 8/3/2026+0.60
https://www.zacks.com/stock/news/2955722/here-s-why-you-should-retain-insp-stock-in-your-portfolio-for-now?cid=CS-STOCKNEWSAPI-FT-analyst_blog|rank_focused-2955722 · 7/17/2026+0.60
https://www.prnewswire.com/news-releases/monolithic-power-investigation-initiated-kahn-swick--foti-llc-investigates-the-officers-and-directors-of-monolithic-power-systems-inc---mpwr-302823086.html · 7/11/2026-0.50
https://www.prnewswire.com/news-releases/inspire-medical-investigation-continued-kahn-swick--foti-llc-continues-to-investigate-the-officers-and-directors-of-inspire-medical-systems-inc---insp-302823089.html · 7/11/2026
https://www.businesswire.com/news/home/20260629996282/en/Inspire-Medical-Investigation-Continued-Kahn-Swick-Foti-LLC-Continues-to-Investigate-the-Officers-and-Directors-of-Inspire-Medical-Systems-Inc.---INSP/ · 6/29/2026-0.80
https://www.zacks.com/stock/news/2915101/inspire-medical-q1-earnings-beat-estimates-2026-view-cut-stock-down?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2915101 · 5/5/2026-0.30
https://www.globenewswire.com/news-release/2026/04/06/3268380/0/en/Inspire-Medical-Systems-Inc-to-Report-First-Quarter-2026-Financial-Results-on-May-4-2026.html · 4/6/2026+0.60
https://www.benzinga.com/trading-ideas/long-ideas/26/03/51373991/top-3-health-care-stocks-that-are-set-to-fly-in-march · 3/20/2026+0.50
https://www.prnewswire.com/news-releases/inspire-medical-investigation-initiated-kahn-swick--foti-llc-investigates-the-officers-and-directors-of-inspire-medical-systems-inc---insp-302688059.html · 2/14/2026-1.00
https://www.zacks.com/stock/news/2846821/inspire-insp-q4-earnings-preview-what-you-should-know-beyond-the-headline-estimates?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_preview-2846821 · 2/10/2026-0.60
https://www.zacks.com/stock/news/2813162/tem-s-stable-solvency-and-financial-strength-are-gaining-attention?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2813162 · 1/7/2026+0.50
https://www.prnewswire.com/news-releases/the-gross-law-firm-reminds-inspire-medical-systems-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-january-5-2026--insp-302651884.html · 1/5/2026-1.00
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
